John M Clements1, Brady T West2, Zachary Yaker3, Breanna Lauinger3, Deven McCullers3, James Haubert3, Mohammad Ali Tahboub3, Gregory J Everett3. 1. Central Michigan University, College of Medicine, 1280 East Campus Dr., Mount Pleasant, MI 48859, United States. Electronic address: clemen69@msu.edu. 2. Survey Research Center, Institute for Social Research, University of Michigan-Ann Arbor, United States. 3. Central Michigan University, College of Medicine, 1280 East Campus Dr., Mount Pleasant, MI 48859, United States.
Abstract
AIMS: The aims of this study are to confirm disparities in diabetes mortality rates based on race, determine if race predicts combinations of diabetes and multiple chronic conditions (MCC) that are leading causes of death (LCD), and determine if combinations of diabetes plus MCC mediate the relationship between race and mortality. METHODS: We performed a retrospective cohort study of 443,932 Medicare beneficiaries in the State of Michigan with type 2 diabetes mellitus and MCC. We applied Cox proportional hazards regression to determine predictors of mortality. We applied multinomial logistic regression to determine predictors of MCC combinations. RESULTS: We found that race influences mortality in Medicare beneficiaries with Type 2 diabetes mellitus and MCC. Prior to adjusting for MCC combinations, we observed that Blacks and American Indian/Alaska Natives have increased risk of mortality compared to Whites, while there is no difference in mortality between Hispanics and Whites. Regarding MCC combinations, Black/African American beneficiaries experience increased odds for most MCC combinations while Asian/Pacific Islanders and Hispanics experience lower odds for MCC combinations, compared to Whites. When adjusting for MCC, mortality disparities observed between Whites, Black/African Americans, and American Indians/Alaska Natives persist. CONCLUSIONS: Compared to Whites, Black/African Americans in our cohort had increased odds of most MCC combinations, and an increased risk of mortality that persisted even after adjusting for MCC combinations.
AIMS: The aims of this study are to confirm disparities in diabetes mortality rates based on race, determine if race predicts combinations of diabetes and multiple chronic conditions (MCC) that are leading causes of death (LCD), and determine if combinations of diabetes plus MCC mediate the relationship between race and mortality. METHODS: We performed a retrospective cohort study of 443,932 Medicare beneficiaries in the State of Michigan with type 2 diabetes mellitus and MCC. We applied Cox proportional hazards regression to determine predictors of mortality. We applied multinomial logistic regression to determine predictors of MCC combinations. RESULTS: We found that race influences mortality in Medicare beneficiaries with Type 2 diabetes mellitus and MCC. Prior to adjusting for MCC combinations, we observed that Blacks and American Indian/Alaska Natives have increased risk of mortality compared to Whites, while there is no difference in mortality between Hispanics and Whites. Regarding MCC combinations, Black/African American beneficiaries experience increased odds for most MCC combinations while Asian/Pacific Islanders and Hispanics experience lower odds for MCC combinations, compared to Whites. When adjusting for MCC, mortality disparities observed between Whites, Black/African Americans, and American Indians/Alaska Natives persist. CONCLUSIONS: Compared to Whites, Black/African Americans in our cohort had increased odds of most MCC combinations, and an increased risk of mortality that persisted even after adjusting for MCC combinations.
Authors: Eldrin F Lewis; Brian Claggett; Patrick S Parfrey; Emmanuel A Burdmann; John J V McMurray; Scott D Solomon; Andrew S Levey; Peter Ivanovich; Kai-Uwe Eckardt; Reshma Kewalramani; Robert Toto; Marc A Pfeffer Journal: Am Heart J Date: 2015-05-22 Impact factor: 4.749
Authors: Anna H Wu; Allison W Kurian; Marilyn L Kwan; Esther M John; Yani Lu; Theresa H M Keegan; Scarlett Lin Gomez; Iona Cheng; Salma Shariff-Marco; Bette J Caan; Valerie S Lee; Jane Sullivan-Halley; Chiu-Chen Tseng; Leslie Bernstein; Richard Sposto; Cheryl Vigen Journal: Cancer Epidemiol Biomarkers Prev Date: 2014-11-25 Impact factor: 4.254
Authors: Donald Lloyd-Jones; Robert Adams; Mercedes Carnethon; Giovanni De Simone; T Bruce Ferguson; Katherine Flegal; Earl Ford; Karen Furie; Alan Go; Kurt Greenlund; Nancy Haase; Susan Hailpern; Michael Ho; Virginia Howard; Brett Kissela; Steven Kittner; Daniel Lackland; Lynda Lisabeth; Ariane Marelli; Mary McDermott; James Meigs; Dariush Mozaffarian; Graham Nichol; Christopher O'Donnell; Veronique Roger; Wayne Rosamond; Ralph Sacco; Paul Sorlie; Randall Stafford; Julia Steinberger; Thomas Thom; Sylvia Wasserthiel-Smoller; Nathan Wong; Judith Wylie-Rosett; Yuling Hong Journal: Circulation Date: 2008-12-15 Impact factor: 29.690
Authors: Kumar B Rajan; Zoe Arvanitakis; Elizabeth B Lynch; Elizabeth A McAninch; Robert S Wilson; Jennifer Weuve; Lisa L Barnes; Antonio C Bianco; Denis A Evans Journal: Neurology Date: 2016-09-21 Impact factor: 9.910
Authors: Vanessa A Palzes; Andrea H Kline-Simon; Derek D Satre; Stacy Sterling; Constance Weisner; Felicia W Chi Journal: Addiction Date: 2021-07-12 Impact factor: 6.526
Authors: Rosita Zakeri; Rebecca Bendayan; Mark Ashworth; Daniel M Bean; Hiten Dodhia; Stevo Durbaba; Kevin O'Gallagher; Claire Palmer; Vasa Curcin; Elizabeth Aitken; William Bernal; Richard D Barker; Sam Norton; Martin Gulliford; James T H Teo; James Galloway; Richard J B Dobson; Ajay M Shah Journal: EClinicalMedicine Date: 2020-10-09